Microalbuminuria is associated with increased risk for renal and cardiovascular mortality and morbidity in diabetes mellitus, hypertension and patients with acute myocardial infarction but the significance of microalbuminuria in other chronic diseases has been very rarely explored. This article highlights the pathogenesis, implications and methodology of testing for microalbuminuria in various systemic disorders.